clinical trials

Psilocybin research was "outlawed" in the 70s, but it's back now. It may offer a powerful new tool for treating addictions to substances such as alcohol, cigarettes, and opioids.

Pregnant people with mental health disorders such as depression or bipolar disorder often face an impossible decision: risk their health or their future child's health by discontinuing or continuing their medication.

Christine Brown develops CAR T cell therapies that may one day provide a long-sought-after cure for malignant brain cancers.

Researchers are conducting the first long-term prospective study to understand the immune response to COVID-19 long after initial infection.

Researchers plan to monitor the immune responses of COVID-19 patients for one year to see how they correlate with illness severity and lasting effects. This data will help develop personalized treatments for patients.

An upcoming clinical study will test whether a B. infantis probiotic can prevent the development of type 1 diabetes in predisposed infants.

Sævik measures corticosteroid levels in people with Addison’s disease to challenge the pervasive idea that these patients lose all adrenal cortex function as their disease progresses.

Spending an hour every day listening to a low-pitched thrum and gazing at blinking lights may help prevent structural changes in the brain and cognitive impairments associated with Alzheimer’s disease.

Protalix and Chiesi share encouraging data from Phase 3 trial evaluating pegunigalsidase alfa in Fabry disease

Topline data from a recent Eli Lilly clinical trial indicate that tirzepatide led to superior A1C and body weight reductions from baseline compared to injectable semaglutide in adults with type 2 diabetes.